NYSE - Delayed Quote USD

American Well Corporation (AMWL)

Compare
9.50 +0.04 (+0.42%)
At close: September 27 at 4:00 PM EDT
9.70 +0.20 (+2.11%)
Pre-Market: 7:20 AM EDT
Loading Chart for AMWL
DELL
  • Previous Close 9.46
  • Open 9.71
  • Bid --
  • Ask 11.27 x 1100
  • Day's Range 9.33 - 9.64
  • 52 Week Range 5.00 - 31.60
  • Volume 27,855
  • Avg. Volume 139,370
  • Market Cap (intraday) 142.414M
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) --
  • EPS (TTM) -21.08
  • Earnings Date Oct 30, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 17.20

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

business.amwell.com

1,104

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AMWL

View More

Performance Overview: AMWL

Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AMWL
68.12%
S&P 500
20.30%

1-Year Return

AMWL
59.75%
S&P 500
34.27%

3-Year Return

AMWL
95.13%
S&P 500
28.79%

5-Year Return

AMWL
98.14%
S&P 500
70.93%

Compare To: AMWL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMWL

View More

Valuation Measures

Annual
As of 9/27/2024
  • Market Cap

    142.41M

  • Enterprise Value

    -124.51M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.54

  • Price/Book (mrq)

    0.39

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -120.44%

  • Return on Assets (ttm)

    -23.03%

  • Return on Equity (ttm)

    -60.92%

  • Revenue (ttm)

    254.91M

  • Net Income Avi to Common (ttm)

    -307.03M

  • Diluted EPS (ttm)

    -21.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    276.91M

  • Total Debt/Equity (mrq)

    2.64%

  • Levered Free Cash Flow (ttm)

    -83.08M

Research Analysis: AMWL

View More

Company Insights: AMWL

Research Reports: AMWL

View More

People Also Watch